img

Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Transient Receptor Potential Cation Channel Subfamily V Member 1 report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Ophthalmology and Immunology are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Transient Receptor Potential Cation Channel Subfamily V Member 1 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Transient Receptor Potential Cation Channel Subfamily V Member 1 key companies include Amgen Inc, Amorepacific Corp, BCN Peptides SA, Centrexion Therapeutics Corp, Daewoong Pharmaceutical Co Ltd, DoNatur GmbH, Flex Pharma Inc, Grunenthal GmbH and Kyowa Hakko Kirin Co Ltd, etc. Amgen Inc, Amorepacific Corp, BCN Peptides SA are top 3 players and held % share in total in 2022.
Transient Receptor Potential Cation Channel Subfamily V Member 1 can be divided into CMX-020, CA-016, DD-04107 and Others, etc. CMX-020 is the mainstream product in the market, accounting for % share globally in 2022.
Transient Receptor Potential Cation Channel Subfamily V Member 1 is widely used in various fields, such as Ophthalmology, Immunology, Muscle Spasm and Pruritus, etc. Ophthalmology provides greatest supports to the Transient Receptor Potential Cation Channel Subfamily V Member 1 industry development. In 2022, global % share of Transient Receptor Potential Cation Channel Subfamily V Member 1 went into Ophthalmology filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transient Receptor Potential Cation Channel Subfamily V Member 1 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Amgen Inc
Amorepacific Corp
BCN Peptides SA
Centrexion Therapeutics Corp
Daewoong Pharmaceutical Co Ltd
DoNatur GmbH
Flex Pharma Inc
Grunenthal GmbH
Kyowa Hakko Kirin Co Ltd
Medifron DBT Co Ltd
Neurim Pharmaceuticals Ltd
Pila Pharma AB
Sylentis SAU
Toray Industries Inc
Vitality Biopharma Inc
Segment by Type
CMX-020
CA-016
DD-04107
Others

Segment by Application


Ophthalmology
Immunology
Muscle Spasm
Pruritus
Abdominal Pain
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Transient Receptor Potential Cation Channel Subfamily V Member 1 market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Transient Receptor Potential Cation Channel Subfamily V Member 1 introduction, etc. Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Transient Receptor Potential Cation Channel Subfamily V Member 1 market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Market Overview of Transient Receptor Potential Cation Channel Subfamily V Member 1
1.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Overview
1.1.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Scope
1.1.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Status and Outlook
1.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2018-2034)
1.4 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Size by Region (2018-2024)
1.5 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034)
1.6.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034)
1.6.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034)
1.6.3 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034)
1.6.4 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034)
1.6.5 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034)
2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Type
2.1 Introduction
2.1.1 CMX-020
2.1.2 CA-016
2.1.3 DD-04107
2.1.4 Others
2.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Size by Type (2018-2024)
2.2.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Breakdown by Type (2018-2034)
3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Overview by Application
3.1 Introduction
3.1.1 Ophthalmology
3.1.2 Immunology
3.1.3 Muscle Spasm
3.1.4 Pruritus
3.1.5 Abdominal Pain
3.1.6 Others
3.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Size by Application (2018-2024)
3.2.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Breakdown by Application (2018-2034)
4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Competition Analysis by Players
4.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 as of 2022)
4.3 Date of Key Players Enter into Transient Receptor Potential Cation Channel Subfamily V Member 1 Market
4.4 Global Top Players Transient Receptor Potential Cation Channel Subfamily V Member 1 Headquarters and Area Served
4.5 Key Players Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Solution and Service
4.6 Competitive Status
4.6.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Amgen Inc
5.1.1 Amgen Inc Profile
5.1.2 Amgen Inc Main Business
5.1.3 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
5.1.4 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million) & (2018-2024)
5.1.5 Amgen Inc Recent Developments
5.2 Amorepacific Corp
5.2.1 Amorepacific Corp Profile
5.2.2 Amorepacific Corp Main Business
5.2.3 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
5.2.4 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million) & (2018-2024)
5.2.5 Amorepacific Corp Recent Developments
5.3 BCN Peptides SA
5.3.1 BCN Peptides SA Profile
5.3.2 BCN Peptides SA Main Business
5.3.3 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
5.3.4 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million) & (2018-2024)
5.3.5 Centrexion Therapeutics Corp Recent Developments
5.4 Centrexion Therapeutics Corp
5.4.1 Centrexion Therapeutics Corp Profile
5.4.2 Centrexion Therapeutics Corp Main Business
5.4.3 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
5.4.4 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million) & (2018-2024)
5.4.5 Centrexion Therapeutics Corp Recent Developments
5.5 Daewoong Pharmaceutical Co Ltd
5.5.1 Daewoong Pharmaceutical Co Ltd Profile
5.5.2 Daewoong Pharmaceutical Co Ltd Main Business
5.5.3 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
5.5.4 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million) & (2018-2024)
5.5.5 Daewoong Pharmaceutical Co Ltd Recent Developments
5.6 DoNatur GmbH
5.6.1 DoNatur GmbH Profile
5.6.2 DoNatur GmbH Main Business
5.6.3 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
5.6.4 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million) & (2018-2024)
5.6.5 DoNatur GmbH Recent Developments
5.7 Flex Pharma Inc
5.7.1 Flex Pharma Inc Profile
5.7.2 Flex Pharma Inc Main Business
5.7.3 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
5.7.4 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million) & (2018-2024)
5.7.5 Flex Pharma Inc Recent Developments
5.8 Grunenthal GmbH
5.8.1 Grunenthal GmbH Profile
5.8.2 Grunenthal GmbH Main Business
5.8.3 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
5.8.4 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million) & (2018-2024)
5.8.5 Grunenthal GmbH Recent Developments
5.9 Kyowa Hakko Kirin Co Ltd
5.9.1 Kyowa Hakko Kirin Co Ltd Profile
5.9.2 Kyowa Hakko Kirin Co Ltd Main Business
5.9.3 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
5.9.4 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million) & (2018-2024)
5.9.5 Kyowa Hakko Kirin Co Ltd Recent Developments
5.10 Medifron DBT Co Ltd
5.10.1 Medifron DBT Co Ltd Profile
5.10.2 Medifron DBT Co Ltd Main Business
5.10.3 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
5.10.4 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million) & (2018-2024)
5.10.5 Medifron DBT Co Ltd Recent Developments
5.11 Neurim Pharmaceuticals Ltd
5.11.1 Neurim Pharmaceuticals Ltd Profile
5.11.2 Neurim Pharmaceuticals Ltd Main Business
5.11.3 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
5.11.4 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million) & (2018-2024)
5.11.5 Neurim Pharmaceuticals Ltd Recent Developments
5.12 Pila Pharma AB
5.12.1 Pila Pharma AB Profile
5.12.2 Pila Pharma AB Main Business
5.12.3 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
5.12.4 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million) & (2018-2024)
5.12.5 Pila Pharma AB Recent Developments
5.13 Sylentis SAU
5.13.1 Sylentis SAU Profile
5.13.2 Sylentis SAU Main Business
5.13.3 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
5.13.4 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million) & (2018-2024)
5.13.5 Sylentis SAU Recent Developments
5.14 Toray Industries Inc
5.14.1 Toray Industries Inc Profile
5.14.2 Toray Industries Inc Main Business
5.14.3 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
5.14.4 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million) & (2018-2024)
5.14.5 Toray Industries Inc Recent Developments
5.15 Vitality Biopharma Inc
5.15.1 Vitality Biopharma Inc Profile
5.15.2 Vitality Biopharma Inc Main Business
5.15.3 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
5.15.4 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million) & (2018-2024)
5.15.5 Vitality Biopharma Inc Recent Developments
6 North America
6.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2018-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Dynamics
11.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Trends
11.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Drivers
11.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Challenges
11.4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Region (2018-2024)
Table 4. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2018-2024)
Table 9. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2024-2034)
Table 11. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2018-2024)
Table 24. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2024-2034)
Table 26. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 as of 2022)
Table 39. Date of Key Players Enter into Transient Receptor Potential Cation Channel Subfamily V Member 1 Market
Table 40. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Players Headquarters and Area Served
Table 41. Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Solution and Service
Table 42. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Amgen Inc Basic Information List
Table 45. Amgen Inc Description and Business Overview
Table 46. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
Table 47. Revenue (US$ Million) in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business of Amgen Inc (2018-2024)
Table 48. Amgen Inc Recent Developments
Table 49. Amorepacific Corp Basic Information List
Table 50. Amorepacific Corp Description and Business Overview
Table 51. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
Table 52. Revenue (US$ Million) in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business of Amorepacific Corp (2018-2024)
Table 53. Amorepacific Corp Recent Developments
Table 54. BCN Peptides SA Basic Information List
Table 55. BCN Peptides SA Description and Business Overview
Table 56. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
Table 57. Revenue (US$ Million) in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business of BCN Peptides SA (2018-2024)
Table 58. BCN Peptides SA Recent Developments
Table 59. Centrexion Therapeutics Corp Basic Information List
Table 60. Centrexion Therapeutics Corp Description and Business Overview
Table 61. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
Table 62. Revenue (US$ Million) in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business of Centrexion Therapeutics Corp (2018-2024)
Table 63. Centrexion Therapeutics Corp Recent Developments
Table 64. Daewoong Pharmaceutical Co Ltd Basic Information List
Table 65. Daewoong Pharmaceutical Co Ltd Description and Business Overview
Table 66. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
Table 67. Revenue (US$ Million) in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business of Daewoong Pharmaceutical Co Ltd (2018-2024)
Table 68. Daewoong Pharmaceutical Co Ltd Recent Developments
Table 69. DoNatur GmbH Basic Information List
Table 70. DoNatur GmbH Description and Business Overview
Table 71. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
Table 72. Revenue (US$ Million) in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business of DoNatur GmbH (2018-2024)
Table 73. DoNatur GmbH Recent Developments
Table 74. Flex Pharma Inc Basic Information List
Table 75. Flex Pharma Inc Description and Business Overview
Table 76. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
Table 77. Revenue (US$ Million) in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business of Flex Pharma Inc (2018-2024)
Table 78. Flex Pharma Inc Recent Developments
Table 79. Grunenthal GmbH Basic Information List
Table 80. Grunenthal GmbH Description and Business Overview
Table 81. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
Table 82. Revenue (US$ Million) in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business of Grunenthal GmbH (2018-2024)
Table 83. Grunenthal GmbH Recent Developments
Table 84. Kyowa Hakko Kirin Co Ltd Basic Information List
Table 85. Kyowa Hakko Kirin Co Ltd Description and Business Overview
Table 86. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
Table 87. Revenue (US$ Million) in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business of Kyowa Hakko Kirin Co Ltd (2018-2024)
Table 88. Kyowa Hakko Kirin Co Ltd Recent Developments
Table 89. Medifron DBT Co Ltd Basic Information List
Table 90. Medifron DBT Co Ltd Description and Business Overview
Table 91. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
Table 92. Revenue (US$ Million) in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business of Medifron DBT Co Ltd (2018-2024)
Table 93. Medifron DBT Co Ltd Recent Developments
Table 94. Neurim Pharmaceuticals Ltd Basic Information List
Table 95. Neurim Pharmaceuticals Ltd Description and Business Overview
Table 96. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
Table 97. Revenue (US$ Million) in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business of Neurim Pharmaceuticals Ltd (2018-2024)
Table 98. Neurim Pharmaceuticals Ltd Recent Developments
Table 99. Pila Pharma AB Basic Information List
Table 100. Pila Pharma AB Description and Business Overview
Table 101. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
Table 102. Revenue (US$ Million) in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business of Pila Pharma AB (2018-2024)
Table 103. Pila Pharma AB Recent Developments
Table 104. Sylentis SAU Basic Information List
Table 105. Sylentis SAU Description and Business Overview
Table 106. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
Table 107. Revenue (US$ Million) in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business of Sylentis SAU (2018-2024)
Table 108. Sylentis SAU Recent Developments
Table 109. Toray Industries Inc Basic Information List
Table 110. Toray Industries Inc Description and Business Overview
Table 111. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
Table 112. Revenue (US$ Million) in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business of Toray Industries Inc (2018-2024)
Table 113. Toray Industries Inc Recent Developments
Table 114. Vitality Biopharma Inc Basic Information List
Table 115. Vitality Biopharma Inc Description and Business Overview
Table 116. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Products, Services and Solutions
Table 117. Revenue (US$ Million) in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business of Vitality Biopharma Inc (2018-2024)
Table 118. Vitality Biopharma Inc Recent Developments
Table 119. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2018-2024) & (US$ Million)
Table 120. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2024-2034) & (US$ Million)
Table 121. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2018-2024) & (US$ Million)
Table 122. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2024-2034) & (US$ Million)
Table 123. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 124. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2018-2024) & (US$ Million)
Table 125. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2024-2034) & (US$ Million)
Table 126. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2018-2024)
Table 127. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2024-2034)
Table 128. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 129. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2018-2024) & (US$ Million)
Table 130. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2024-2034) & (US$ Million)
Table 131. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 132. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2018-2024) & (US$ Million)
Table 133. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2024-2034) & (US$ Million)
Table 134. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Trends
Table 135. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Drivers
Table 136. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Challenges
Table 137. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Regions: 2022 VS 2034
Figure 4. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of CMX-020
Figure 11. Global CMX-020 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of CA-016
Figure 13. Global CA-016 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of DD-04107
Figure 15. Global DD-04107 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Product Picture of Others
Figure 17. Global Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 18. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Type: 2022 & 2034
Figure 19. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2018-2034)
Figure 20. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2018-2034)
Figure 21. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2018-2034)
Figure 22. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2018-2034)
Figure 23. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2018-2034)
Figure 24. Ophthalmology Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 25. Immunology Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 26. Muscle Spasm Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 27. Pruritus Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 28. Abdominal Pain Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 29. Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 30. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Application: 2022 & 2034
Figure 31. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2018-2034)
Figure 32. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2018-2034)
Figure 33. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2018-2034)
Figure 34. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2018-2034)
Figure 35. Middle East and Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2018-2034)
Figure 36. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 37. Global Top 5 and Top 10 Players Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share in 2022
Figure 38. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2018-2034)
Figure 39. U.S. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 40. Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 41. Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 42. France Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 43. U.K. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 44. Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 45. Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 46. Nordic Countries Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 47. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2018-2034)
Figure 48. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 49. Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 50. South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 51. Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 52. India Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 53. Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 54. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2018-2034)
Figure 55. Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 56. Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 57. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2018-2034)
Figure 58. Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 59. Saudi Arabia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 60. UAE Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2018-2034) & (US$ Million)
Figure 61. Bottom-up and Top-down Approaches for This Report